In continuation of earlier intimation dated April 9, 2025, in compliance with Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it was ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Tejnaksh Healthcare Ltd, at its meeting held on April 15, 2025, approved the draft letter of offer for a proposed Rights Issue of equity shares worth up to Rs. 725 lakhs. The company will file the draft letter of offer with BSE (the designated stock exchange) for approval under SEBI ICDR Regulations, 2018. The Board also decided to keep the proposed shifting of the registered office on hold for the time being. Appointment of agencies and intermediaries for the rights issue was deferred to a later meeting. The trading window remains closed until 48 hours after the announcement of financial results for the year ended March 31, 2025.
This is a capital-raising move through a rights issue, which could lead to dilution of existing shareholders depending on the issue price and ratio. The detailed terms (issue price, ratio, record date) are yet to be announced, so the actual impact on shareholders is still unclear.